Axogen, Inc. (AXGN)
30.78
-0.38
(-1.22%)
USD |
NASDAQ |
Mar 20, 16:00
30.81
+0.03
(+0.10%)
After-Hours: 20:00
Axogen Research and Development Expense (Quarterly) : 12.38M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| CONMED Corp. | 14.90M |
| Dynatronics Corp. | -- |
| Escalon Medical Corp. | 0.1312M |
| IRIDEX Corp. | 0.972M |
| Electromed, Inc. | 0.384M |